CLLS Cellectis S.A.

-

Cellectis S.A. Reported Earnings

Thursday, August 6, 2026 · 12:00 AM ET

Cellectis S.A. (CLLS) reported a loss of $0.22 per share on revenue of $6.90 million for the . . Revenue fell 62.05% compared to the same quarter a year ago.

Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.22)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth8.3 %
Reported Revenue
$6.90M
Revenue Estimate
Revenue Surprise
Revenue Growth-62.1 %